Rankings
▼
Calendar
PTCT FY 2022 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$699M
+29.7% YoY
Gross Profit
$654M
93.6% margin
Operating Income
-$447M
-64.0% margin
Net Income
-$559M
-80.0% margin
EPS (Diluted)
$-7.79
Cash Flow
Operating Cash Flow
-$357M
Free Cash Flow
-$509M
Stock-Based Comp.
$110M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$2.1B
Stockholders' Equity
-$347M
Cash & Equivalents
$280M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$699M
$539M
+29.7%
Gross Profit
$654M
$506M
+29.2%
Operating Income
-$447M
-$374M
-19.5%
Net Income
-$559M
-$524M
-6.7%
← Q4 2021
All Quarters
Q1 2022 →